The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...

Ritedose receives FDA approval for Tobramycin Tobramycin expands nation's largest nebulized drug portfolio. - Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the ...

An announcement from Liquidia Technologies ( ($LQDA) ) is now available. On October 27, 2025, Liquidia Technologies entered into an exclusive ...

The latest announcement is out from BiomX ( (PHGE) ).

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

Texas officials promised to help Rochelle care for her grandkids after taking them from their parents. But the help she ...

Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...

A new clinical practice guideline developed by a task force of the American Academy of Sleep Medicine provides updated ...

Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy ...

BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which are narrow in scope; an additional FDA request for limited technical ...

A recent study published in JAMA Network Open, titled "Health Care Professional Willingness to Treat Opioid Use Disorder vs. Type 2 Diabetes in Primary Care," reveals surprising insights into how ...

Seeing your kiddo go through a scary situation is stressful for any parent. But it can also be a learning experience.